The Introduction of cPRA and Its Impact on Access to Deceased Donor Kidney Transplantation for Highly Sensitized Patients in Australia.
Sign Up to like & getrecommendations! Published in 2020 at "Transplantation"
DOI: 10.1097/tp.0000000000003410
Abstract: BACKGROUND In March 2016, Australia's deceased donor kidney allocation program introduced calculated panel reactive antibody (cPRA) based on antibody exclusions using multiplex assays to define sensitization for waitlisted candidates. We aimed to assess the impact… read more here.
Keywords: introduction cpra; highly sensitized; sensitized patients; deceased donor ... See more keywords
ABOâadjusted calculated panel reactive antibody (cPRA): A unified metric for immunologic compatibility in kidney transplantation
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Transplantation"
DOI: 10.1111/ajt.17175
Abstract: Implementation of the kidney allocation system in 2014 greatly reduced access disparity due to human leukocyte antigen (HLA) sensitization. To address persistent disparity related to candidate ABO blood groups, herein we propose a novel metric… read more here.
Keywords: hla; adjusted cpra; kidney; cpra ... See more keywords
Portuguese calculated panel reactive antibodies online estimator
Sign Up to like & getrecommendations! Published in 2019 at "HLA"
DOI: 10.1111/tan.13516
Abstract: Calculated panel reactive antibodies (CPRA) is a sensitization measure used to classify and prioritize transplant candidates in different kidney transplant allocation systems. CPRA is based on identification of HLA unacceptable on potential organ donors making… read more here.
Keywords: reactive antibodies; cpra; calculated panel; online estimator ... See more keywords